Group One Trading
PAVM icon

Group One Trading’s PAVmed PAVM Stock Holding History

Group One Trading’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$20 – 8245
2026
Q1 		$20 Buy
+2
New +$19 ﹤0.01% 7462
2025
Q4 		– Hold
0
– – – 7975
2025
Q3 		– Hold
0
– – – 8285
2025
Q2 		– Hold
0
– – – 7829
2025
Q1 		– Sell
-74
Closed -$1.53K – 8175
2024
Q4 		$1.4K Buy
+74
New +$2.19K ﹤0.01% 6826
2023
Q4 		– Sell
-242
Closed -$32.1K – 7979
2023
Q3 		$32.1K Sell
242
-19
-7% -$2.95K ﹤0.01% 5489
2023
Q2 		$47.9K Hold
261
– – ﹤0.01% 5306
2023
Q1 		$43.9K Buy
261
+13
+5% +$2.74K ﹤0.01% 4948
2022
Q4 		$53.6K Sell
248
-65
-21% -$24.5K ﹤0.01% 4940
2022
Q3 		$121K Sell
313
-21
-6% -$11.9K ﹤0.01% 4599
2022
Q2 		$140K Buy
334
+18
+6% +$8.7K ﹤0.01% 4657
2022
Q1 		$187K Buy
316
+111
+54% +$82.5K ﹤0.01% 4862
2021
Q4 		$227K Buy
205
+136
+197% +$296K ﹤0.01% 4958
2021
Q3 		$265K Sell
69
-139
-67% -$438K ﹤0.01% 4890
2021
Q2 		$599K Buy
+208
New +$491K ﹤0.01% 4018

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's PAVM Position: Q2 2026 in Review

Group One Trading sold out of PAVmed (PAVM) in Q2 2026, closing a stake of 2 shares — an estimated $20 sold.

Group One Trading first reported a position in PAVM in Q2 2021 and held it in 12 quarters. The position peaked at $599K in Q2 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

  • Group One Trading reported no remaining PAVmed position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 2 PAVmed shares in Q2 2026, an estimated $20.
  • Group One Trading first reported a position in PAVmed in Q2 2021 and held it in 12 quarters.
  • Group One Trading's PAVmed position peaked at $599K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.